Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Gee

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Alzheimer'S Research & Therapy|July 10, 2024
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Alzheimer'S Research & Therapy|May 10, 2024
Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Journal of Biomolecular Screening|August 24, 2011
Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometrySue E Hutchinson, Melanie V Leveridge, Michelle L Heathcote, et al.
Journal of Biomolecular Screening|January 2, 2014
Lead discovery for human kynurenine 3-monooxygenase by high-throughput RapidFire mass spectrometryDenise M Lowe, Michelle Gee, Carl Haslam, et al.
The New England Journal of Medicine|November 30, 2022
Lecanemab in Early Alzheimer's DiseaseChristopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Alzheimer'S Research & Therapy|July 10, 2024
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Alzheimer'S Research & Therapy|May 10, 2024
Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Journal of Biomolecular Screening|August 24, 2011
Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometrySue E Hutchinson, Melanie V Leveridge, Michelle L Heathcote, et al.
Journal of Biomolecular Screening|January 2, 2014
Lead discovery for human kynurenine 3-monooxygenase by high-throughput RapidFire mass spectrometryDenise M Lowe, Michelle Gee, Carl Haslam, et al.
The New England Journal of Medicine|November 30, 2022
Lecanemab in Early Alzheimer's DiseaseChristopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Pageof 3